Cardinal Health (CAH) – Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Cardinal Health (NYSE: CAH) recently:

• 8/13/2026 – Cardinal Health had its price target raised by TD Cowen from $275.00 to $280.00. They now have a “buy” rating on the stock.
• 8/13/2026 – Cardinal Health had its price target raised by Barclays PLC from $258.00 to $275.00. They now have an “overweight” rating on the stock.
• 8/13/2026 – Cardinal Health had its price target raised by JPMorgan Chase & Co. from $215.00 to $260.00. They now have a “neutral” rating on the stock.
• 8/12/2026 – Cardinal Health had its price target raised by Morgan Stanley from $255.00 to $265.00. They now have an “overweight” rating on the stock.
• 8/12/2026 – Cardinal Health had its “outperform” rating reaffirmed by Evercore Inc. They now have a $270.00 price target on the stock.
• 8/12/2026 – Cardinal Health had its price target raised by UBS Group AG from $274.00 to $280.00. They now have a “buy” rating on the stock.
• 8/12/2026 – Cardinal Health had its price target raised by Mizuho from $240.00 to $250.00. They now have an “outperform” rating on the stock.
• 8/12/2026 – Cardinal Health had its price target raised by Citigroup Inc. from $265.00 to $280.00. They now have a “buy” rating on the stock.
• 8/12/2026 – Cardinal Health had its price target raised by Wells Fargo & Company from $245.00 to $277.00. They now have an “overweight” rating on the stock.
• 8/12/2026 – Cardinal Health had its price target raised by Robert W. Baird from $251.00 to $274.00. They now have an “outperform” rating on the stock.
• 8/11/2026 – Cardinal Health was given a new $292.00 price target by Leerink Partners.
• 8/5/2026 – Cardinal Health was upgraded by Weiss Ratings from “buy (b)” to “buy (b+)”.
• 7/24/2026 – Cardinal Health had its price target raised by Citigroup Inc. from $245.00 to $265.00. They now have a “buy” rating on the stock.
• 7/23/2026 – Cardinal Health had its price target raised by Mizuho from $235.00 to $240.00. They now have an “outperform” rating on the stock.
• 7/20/2026 – Cardinal Health had its price target raised by UBS Group AG from $260.00 to $274.00. They now have a “buy” rating on the stock.
• 7/9/2026 – Cardinal Health had its price target raised by TD Cowen from $255.00 to $275.00. They now have a “buy” rating on the stock.
• 7/4/2026 – Cardinal Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 7/2/2026 – Cardinal Health had its “buy” rating reaffirmed by Citigroup Inc..
• 7/2/2026 – Cardinal Health had its price target raised by Bank of America Corporation from $240.00 to $260.00. They now have a “buy” rating on the stock.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio is currently 28.49%.

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.